Print Issues

February 2024 Issue of Becker’s ASC Review ON THE COVER How weight loss drugs may impact the ASC industry Glucagon-like peptide-1 receptor agonists such as Ozempic have surged in popularity over the past year. But what does this increased popularity…

January/February 2024 Issue of Becker’s ASC Review ON THE COVER The new age of ‘super-sized’ ASCs Les Jebson, regional administrator at Greenville, S.C.-based Prisma Health, joined Becker’s to discuss the biggest ASC growth opportunities. ASCs vs. HOPDs: 3 cost comparisons ASCs and…